Artwork

Content provided by Audioboom and OncLive® On Air. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and OncLive® On Air or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S1 Ep18: Keeping Up With Hematologic Advances in Clayton

25:38
 
Share
 

Manage episode 221682255 series 2395115
Content provided by Audioboom and OncLive® On Air. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and OncLive® On Air or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

We visited Clayton, Missouri for a State of the Science Summit on Hematologic Malignancies with faculty from Washington University School of Medicine in St. Louis and Siteman Cancer Center. The meeting covered novel agents and combinations in chronic lymphocytic leukemia, advances in acute myeloid leukemia, management of newly diagnosed and relapsed/refractory multiple myeloma, progress in myeloproliferative neoplasms, patient selection for Hodgkin lymphoma therapy, and current data with chimeric antigen receptor T-cell therapy.

  continue reading

483 episodes

Artwork
iconShare
 
Manage episode 221682255 series 2395115
Content provided by Audioboom and OncLive® On Air. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and OncLive® On Air or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

We visited Clayton, Missouri for a State of the Science Summit on Hematologic Malignancies with faculty from Washington University School of Medicine in St. Louis and Siteman Cancer Center. The meeting covered novel agents and combinations in chronic lymphocytic leukemia, advances in acute myeloid leukemia, management of newly diagnosed and relapsed/refractory multiple myeloma, progress in myeloproliferative neoplasms, patient selection for Hodgkin lymphoma therapy, and current data with chimeric antigen receptor T-cell therapy.

  continue reading

483 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide